510(k) K002376

ADVIA: CENTAUR AND ACS: 180 CPSA ASSAY by Bayer Corp. — Product Code LTJ

K002376 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "ADVIA: CENTAUR AND ACS: 180 CPSA ASSAY". The FDA issued a decision of Substantially Equivalent on October 26, 2000. The device falls under product code LTJ (Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers), a Class II device regulated under 21 CFR 866.6010. Bayer Corp. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 26, 2000
Date Received
August 4, 2000
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
Device Class
Class II
Regulation Number
866.6010
Review Panel
IM
Submission Type